Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

WORK Medical Technology (WOK) Cash & Equivalents (2023 - 2025)

Historic Cash & Equivalents for WORK Medical Technology (WOK) over the last 3 years, with Q3 2025 value amounting to $4.1 million.

  • WORK Medical Technology's Cash & Equivalents fell 3765.1% to $4.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.1 million, marking a year-over-year decrease of 3765.1%. This contributed to the annual value of $4.1 million for FY2025, which is 3765.1% down from last year.
  • Latest data reveals that WORK Medical Technology reported Cash & Equivalents of $4.1 million as of Q3 2025, which was down 3765.1% from $6.6 million recorded in Q1 2025.
  • Over the past 5 years, WORK Medical Technology's Cash & Equivalents peaked at $6.6 million during Q3 2024, and registered a low of $1.6 million during Q3 2023.
  • Over the past 3 years, WORK Medical Technology's median Cash & Equivalents value was $5.3 million (recorded in 2024), while the average stood at $4.7 million.
  • Per our database at Business Quant, WORK Medical Technology's Cash & Equivalents soared by 31085.28% in 2024 and then plummeted by 3765.1% in 2025.
  • Quarter analysis of 3 years shows WORK Medical Technology's Cash & Equivalents stood at $1.6 million in 2023, then surged by 310.85% to $6.6 million in 2024, then crashed by 37.65% to $4.1 million in 2025.
  • Its last three reported values are $4.1 million in Q3 2025, $6.6 million for Q1 2025, and $6.6 million during Q3 2024.